JANX Janux Therapeutics, Inc.
Healthcare$14.40-0.83%ClosedMarket Cap: $878.2M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
1
Buy/Sell Ratio
0.00
Net Shares
-2,038
Shares Acquired
0
Shares Disposed
2,038
Total Bought ($)
$0.00
Total Sold ($)
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed May 13 | Dobek Maria | officer: Vice President, Accounting | Sell | 2,038 | $14.17 | 32,270 |
| Wed Feb 04 | Go William | officer: Chief Medical Officer | Sell | 154,000 | $13.99 | 154,000 |
| Wed Feb 04 | Go William | officer: Chief Medical Officer | Sell | 44,000 | $0.00 | 44,000 |
| Wed Feb 04 | Go William | Sell | 0 | $0.00 | 0 | |
| Fri Jan 02 | Meyer Andrew Hollman | officer: Chief Business Officer | Sell | 1,879 | $13.73 | 83,095 |
| Fri Jan 02 | DiRaimondo Thomas | officer: Chief Scientific Officer | Sell | 2,505 | $13.73 | 124,425 |
| Fri Jan 02 | DiRaimondo Thomas | officer: Chief Scientific Officer | Sell | 109,900 | $13.65 | 109,900 |
| Fri Jan 02 | DiRaimondo Thomas | officer: Chief Scientific Officer | Sell | 31,400 | $0.00 | 155,825 |
| Fri Jan 02 | Campbell David Alan | director, officer: President and CEO | Sell | 8,072 | $13.73 | 284,982 |
| Fri Jan 02 | Campbell David Alan | director, officer: President and CEO | Sell | 338,100 | $13.65 | 338,100 |
| Fri Jan 02 | Campbell David Alan | director, officer: President and CEO | Sell | 96,600 | $0.00 | 381,582 |